In prostate cancer stem cells (PCSCs), IMPA1 upregulation increases inositol levels, which directly bind and activate inosine monophosphate dehydrogenase 2 (IMPDH2), a key enzyme in purine biosynthesis. Here, IMPDH2 is linked to prostate cancer.